CURE: Benefits And Caveats Of The Leveraged Healthcare ETF
Source: SeekingAlpha
2026-01-20 12:39:50 ET
Fast facts and strategy of the Direxion Daily Healthcare Bull 3x Shares ETF
The Direxion Daily Healthcare Bull 3X Shares ETF ( CURE ) is a leveraged ETF with a factor of 3x in the healthcare sector. CURE was launched on June 15, 2011 and has a net expense ratio of 0.93%. It is a small, but quite liquid ETF, with $180 million of AUM (assets under management) and a 3-month average daily dollar volume of $9 million. The issuer Direxion is specialized in leveraged ETFs, with dozens of these products based on equity indexes and single stocks....
Read the full article on Seeking Alpha
For further details see:
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF
ProShares Ultra Nasdaq Biotechnology
NASDAQ: BIB
BIB Trading
-2.29% G/L:
$78.3696 Last:
3,158 Volume:
$79.94 Open:
